Brenntag SE (ETR:BNR - Get Free Report)'s share price was down 0.4% during mid-day trading on Wednesday . The company traded as low as €56.02 ($58.35) and last traded at €56.18 ($58.52). Approximately 254,301 shares traded hands during mid-day trading, The stock had previously closed at €56.40 ($58.75).
Brenntag Stock Down 0.4 %
The company's 50-day moving average is €58.84 and its 200 day moving average is €62.19. The company has a debt-to-equity ratio of 79.55, a quick ratio of 1.19 and a current ratio of 1.72. The company has a market capitalization of $8.11 billion, a PE ratio of 13.67, a P/E/G ratio of 0.39 and a beta of 0.90.
About Brenntag
(
Get Free Report)
Brenntag SE purchases and supplies various industrial and specialty chemicals, and ingredients in Germany, Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company operates in two segments, Brenntag Essentials and Brenntag Specialties. It provides just-in-time delivery, product mixing, blending, repackaging, inventory management, and drum return handling.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Brenntag, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Brenntag wasn't on the list.
While Brenntag currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
